Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination immunotherapy for treatment of melanoma, colon or non-small cell lung cancers

Combination immunotherapy for treatment of melanoma, colon or non-small cell lung cancers

US Patent 12295986 · Granted May 13, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Uses of amphiphiles in immune cell therapy and compositions therefor2025
Fusion polypeptides comprising interleukin 12 and a metal-hydroxide binding poly2025
Fusion polypeptides comprising interleukin 12 and a metal-hydroxide binding poly2025
Immunomodulatory fusion protein-metal hydroxide complexes and methods thereof2025
Immunomodulatory fusion protein-metal hydroxide complexes and methods thereof2025
Methods of activating anti-CD19 chimeric antigen receptor (CAR) T cells using am2025
Methods of activating anti-CD19 chimeric antigen receptor (CAR) T cells using am2025
Delivery of biomolecules to immune cells2025
Synthetic oncolytic LNP-replicon RNA and uses for cancer immunotherapy2025
Synthetic oncolytic LNP-replicon RNA and uses for cancer immunotherapy2025
Immunostimulatory compositions and methods of use thereof2025
Methods for in vitro evolution of constructs derived from viruses2025